Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I9IX
|
||||
| Former ID |
DNC012680
|
||||
| Drug Name |
Tyr-D-Ala-Phe-Thr(-D-Glc)-Tyr-Pro-Ser-NH2
|
||||
| Indication | Discovery agent | Investigative | [534460] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C48H64N8O16
|
||||
| Canonical SMILES |
CC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CO)C(=<br />O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C<br />4)O)N)OC5C(C(C(C(O5)CO)O)O)O
|
||||
| InChI |
1S/C48H64N8O16/c1-24(51-43(66)31(49)19-27-10-14-29(59)15-11-27)42(65)52-32(20-26-7-4-3-5-8-26)44(67)55-37(25(2)71-48-40(63)39(62)38(61)36(23-58)72-48)46(69)53-33(21-28-12-16-30(60)17-13-28)47(70)56-18-6-9-35(56)45(68)54-34(22-57)41(50)64/h3-5,7-8,10-17,24-25,31-40,48,57-63H,6,9,18-23,49H2,1-2H3,(H2,50,64)(H,51,66)(H,52,65)(H,53,69)(H,54,68)(H,55,67)/t24-,25-,31+,32+,33+,34+,35+,36?,37+,38?,39?,40?,48?/m1/s1
|
||||
| InChIKey |
SAWFTOJFOXCLCQ-UWLFGCPPSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [534460] | |
| Mu-type opioid receptor | Target Info | Inhibitor | [534460] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.